{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-024515","form_type":"8-K","ticker":"SPRB","cik":"0001683553","company_name":"SPRUCE BIOSCIENCES, INC.","filed_at":"2023-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.029842+00:00","generated_at":"2026-06-14T13:08:47.181043+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Spruce Biosciences stockholders elect three Class III directors, ratify BDO USA as auditor","bullets":["Javier Szwarcberg elected Class III director with 30,521,567 votes for, 32,730 withheld.","Michael Grey elected Class III director with 30,443,905 votes for, 110,392 withheld.","Camilla V. Simpson elected Class III director with 29,471,049 votes for, 1,083,248 withheld.","Stockholders ratified BDO USA as independent auditor for FY 2023: 33,479,638 for, 11,138 against, 5,540 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-024515","json":"https://secwatch.observer/filing/0000950170-23-024515.json","markdown":"https://secwatch.observer/filing/0000950170-23-024515.md","text":"https://secwatch.observer/filing/0000950170-23-024515.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1683553/000095017023024515/0000950170-23-024515-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1683553/000095017023024515/sprb-20230525.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T13:08:47.181043+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e06216afeec5b5cfaf4e13c635e815137f6c5b1","claim":"SPRUCE BIOSCIENCES, INC. shareholders approved Election of Directors at the 2023-05-25 meeting.","evidence_excerpt":"Proposal 1. Election of Directors The Company’s stockholders elected the three persons listed below as Class III Directors, each to serve until the Company’s 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1683553/000095017023024515/0000950170-23-024515-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"c666194a287fbd83edfe92165fab500f1a65c4cd","claim":"SPRUCE BIOSCIENCES, INC. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2023-05-25 meeting.","evidence_excerpt":"Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1683553/000095017023024515/0000950170-23-024515-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}